Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
0.1272
+0.0062 (5.12%)
At close: Mar 13, 2026, 4:00 PM EDT
0.1225
-0.0047 (-3.69%)
After-hours: Mar 13, 2026, 7:59 PM EDT

Propanc Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
216110-
Market Cap Growth
-2651.53%-26.11%3648548.65%--
Enterprise Value
2.0117.1210.880.040
Last Close Price
0.134.1575.008100.007.40103.40
PE Ratio
--0.28-0.05-0.080.000.00
PB Ratio
0.161.18-0.16-0.260.00-
P/TBV Ratio
0.131.18-0.03-0.0700
P/FCF Ratio
--40.64-0.64-0.730.00-
P/OCF Ratio
--40.64-0.64-0.730.00-
EV/EBITDA Ratio
--0.30-0.66-0.50-0.02-
EV/EBIT Ratio
--0.30-0.65-0.50-0.02-
EV/FCF Ratio
--42.25-1.07-0.80-0.03-
Debt / Equity Ratio
0.010.05-0.11-0.03-0.010
Debt / EBITDA Ratio
0.00-0.02-0.56-0.28-0.50-0.34
Debt / FCF Ratio
-0.06-2.98-0.90-0.45-0.69-0.55
Net Debt / Equity Ratio
0.020.09-0.22-0.16-0.33-0.20
Net Debt / EBITDA Ratio
0.00-0.02-0.54-0.28-0.50-0.34
Net Debt / FCF Ratio
-0.06-2.98-0.88-0.44-0.69-0.54
Quick Ratio
0.000.000.010.000.000.00
Current Ratio
2.131.500.010.010.000.00
Return on Equity (ROE)
-1811.69%-1163.67%60.29%95.11%90.89%67.16%
Return on Assets (ROA)
-857.17%-581.38%-2161.85%-2386.23%-4117.12%-3074.88%
Return on Invested Capital (ROIC)
-1191.10%-781.63%79.91%115.62%119.19%101.05%
Return on Capital Employed (ROCE)
-1756.89%-1108.63%45.06%58.45%65.83%54.02%
Earnings Yield
-3490.33%-357.83%-1894.04%-1332.05%-39916216.22%-46260928.43%
FCF Yield
-163.13%-2.46%-156.24%-136.45%-6469837.84%-
Buyback Yield / Dilution
-48.07%0.00%-3.85%-64.63%-3262549.55%-
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.